Compare IMA & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMA | CMBM |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4M | 65.5M |
| IPO Year | N/A | 2019 |
| Metric | IMA | CMBM |
|---|---|---|
| Price | $6.70 | $1.75 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 48.2K | ★ 445.5K |
| Earning Date | 02-15-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $800,000.00 | ★ $172,215,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.70 | $0.23 |
| 52 Week High | $18.00 | $6.80 |
| Indicator | IMA | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.44 |
| Support Level | N/A | $1.44 |
| Resistance Level | N/A | $1.68 |
| Average True Range (ATR) | 0.00 | 0.14 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 87.48 |
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.